HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by Brafman, A. Articles by Shoshani, T. Search for Related Content PubMed PubMed Citation Articles by Brafman, A. Articles by Shoshani, T.

Inhibition of Oxygen-Induced Retinopathy in RTP801-Deficient Mice

¹From Quark Biotech, Inc., Fremont, California; and the ²Department of Ophthalmology, Assaf Harofeh Medical Center, Sackler School of Medicine Tel-Aviv University, Zerifin, Israel.

PURPOSE. Ischemic proliferative retinopathy, which occurs as a complication of diabetes mellitus, prematurity, or retinal vein occlusion, is a major cause of blindness worldwide. In addition to retinal neovascularization, it involves retinal degeneration, of which apoptosis is the main cause. A prior report has described the cloning of a novel HIF-1–responsive gene, RTP801, which displays strong hypoxia-dependent upregulation in ischemic cells of neuronal origin, both in vitro and in vivo. Moreover, inducible overexpression of RTP801 promotes the apoptotic death of differentiated neuron-like PC12 cells and increases their sensitivity to ischemic injury and oxidative stress. The purpose of the study was to examine the potential role of RTP801 in the pathogenesis of retinopathy, using RTP801-deficient mice.

METHODS. Wild-type and RTP801-knockout mice were used in a model of retinopathy of prematurity (ROP). Their retinas were collected at postnatal day (P)14 and P17. They were examined by fluorescein angiography and by analysis of VEGF expression, neovascularization, and apoptosis.

RESULTS. The expression of RTP801 was induced in the wild-type retina after hypoxia treatment. The retinal expression of VEGF after transfer to normoxic conditions was similarly upregulated in both wild-type and knockout mice. Nevertheless, the retinas of the RTP801-knockout mice in an ROP model showed a significant reduction in retinal neovascularization (P < 0.0001) and in the number of apoptotic cells in the inner nuclear layer (P < 0.0001).

CONCLUSIONS. In the absence of RTP801 expression, development of retinopathy in the mouse model of ROP was significantly attenuated, thus implying an important role of RTP801 in the pathogenesis of ROP.

This article has been cited by other articles:

				C. Malagelada, E. J. Ryu, S. C. Biswas, V. Jackson-Lewis, and L. A. Greene RTP801 Is Elevated in Parkinson Brain Substantia Nigral Neurons and Mediates Death in Cellular Models of Parkinson's Disease by a Mechanism Involving Mammalian Target of Rapamycin Inactivation J. Neurosci., September 27, 2006; 26(39): 9996 - 10005. [Abstract] [Full Text] [PDF]

				A. L. Dorfman, O. Dembinska, S. Chemtob, and P. Lachapelle Structural and functional consequences of trolox C treatment in the rat model of postnatal hyperoxia. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 1101 - 1108. [Abstract] [Full Text] [PDF]

				A. Sofer, K. Lei, C. M. Johannessen, and L. W. Ellisen Regulation of mTOR and Cell Growth in Response to Energy Stress by REDD1 Mol. Cell. Biol., July 15, 2005; 25(14): 5834 - 5845. [Abstract] [Full Text] [PDF]